Lazard Asset Management
MIRM icon

Lazard Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Lazard Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Hold
1,981
– – ﹤0.01% 1628
2026
Q1 		$183K Hold
1,981
– – ﹤0.01% 1643
2025
Q4 		$156K Hold
1,981
– – ﹤0.01% 1683
2025
Q3 		$145K Buy
1,981
+19
+1% +$1.21K ﹤0.01% 1643
2025
Q2 		$99K Sell
1,962
-40
-2% -$1.78K ﹤0.01% 1865
2025
Q1 		$90K Sell
2,002
-262
-12% -$12.3K ﹤0.01% 1836
2024
Q4 		$93K Sell
2,264
-69
-3% -$2.88K ﹤0.01% 1821
2024
Q3 		$90K Buy
+2,333
New +$93.1K ﹤0.01% 1797
2024
Q2 		– Sell
-74
Closed -$1K – 2358
2024
Q1 		$1K Sell
74
-2,442
-97% -$67.1K ﹤0.01% 1985
2023
Q4 		$74K Buy
2,516
+74
+3% +$2.24K ﹤0.01% 1776
2023
Q3 		$77K Hold
2,442
– – ﹤0.01% 1718
2023
Q2 		$63K Sell
2,442
-1,116
-31% -$29.7K ﹤0.01% 1752
2023
Q1 		$85K Buy
3,558
+1,116
+46% +$25.4K ﹤0.01% 1599
2022
Q4 		$47K Hold
2,442
– – ﹤0.01% 1848
2022
Q3 		$51K Hold
2,442
– – ﹤0.01% 1797
2022
Q2 		$47K Buy
+2,442
New +$57.6K ﹤0.01% 1846
2021
Q4 		– Sell
-3,599
Closed -$71K – 2395
2021
Q3 		$71K Buy
+3,599
New +$58.5K ﹤0.01% 1528

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's MIRM Position: Q2 2026 in Review

Lazard Asset Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 1,981 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Lazard Asset Management first reported a position in MIRM in Q3 2021 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Lazard Asset Management held 1,981 shares of Mirum Pharmaceuticals worth $232K as of Q2 2026.
  • Lazard Asset Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1628 holding.
  • Lazard Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.